Standard
Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. / Bergstrom, Christel A. S.; Box, Karl; Holm, Rene; Matthews, Wayne; McAllister, Mark; Mullertz, Anette; Rades, Thomas; Schaefer, Kerstin J.; Teleki, Alexandra.
In:
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 139, 06.2019, p. 101-114.
Research output: Contribution to journal › Review › Research › peer-review
Harvard
Bergstrom, CAS, Box, K, Holm, R, Matthews, W, McAllister, M
, Mullertz, A, Rades, T, Schaefer, KJ & Teleki, A 2019, '
Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects',
European Journal of Pharmaceutics and Biopharmaceutics, vol. 139, pp. 101-114.
https://doi.org/10.1016/j.ejpb.2019.03.011APA
Bergstrom, C. A. S., Box, K., Holm, R., Matthews, W., McAllister, M.
, Mullertz, A., Rades, T., Schaefer, K. J., & Teleki, A. (2019).
Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects.
European Journal of Pharmaceutics and Biopharmaceutics,
139, 101-114.
https://doi.org/10.1016/j.ejpb.2019.03.011Vancouver
Bergstrom CAS, Box K, Holm R, Matthews W, McAllister M
, Mullertz A et al.
Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects.
European Journal of Pharmaceutics and Biopharmaceutics. 2019 Jun;139:101-114.
https://doi.org/10.1016/j.ejpb.2019.03.011Author
Bergstrom, Christel A. S. ; Box, Karl ; Holm, Rene ; Matthews, Wayne ; McAllister, Mark ; Mullertz, Anette ; Rades, Thomas ; Schaefer, Kerstin J. ; Teleki, Alexandra. / Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects. In: European Journal of Pharmaceutics and Biopharmaceutics. 2019 ; Vol. 139. pp. 101-114.
Bibtex
@article{d62e70d99e0d4ce19465593626cfac58,
title = "Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects",
author = "Bergstrom, {Christel A. S.} and Karl Box and Rene Holm and Wayne Matthews and Mark McAllister and Anette Mullertz and Thomas Rades and Schaefer, {Kerstin J.} and Alexandra Teleki",
year = "2019",
month = jun,
doi = "10.1016/j.ejpb.2019.03.011",
language = "English",
volume = "139",
pages = "101--114",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - Biorelevant intrinsic dissolution profiling in early drug development: Fundamental, methodological, and industrial aspects
AU - Bergstrom, Christel A. S.
AU - Box, Karl
AU - Holm, Rene
AU - Matthews, Wayne
AU - McAllister, Mark
AU - Mullertz, Anette
AU - Rades, Thomas
AU - Schaefer, Kerstin J.
AU - Teleki, Alexandra
PY - 2019/6
Y1 - 2019/6
U2 - 10.1016/j.ejpb.2019.03.011
DO - 10.1016/j.ejpb.2019.03.011
M3 - Review
C2 - 30862481
VL - 139
SP - 101
EP - 114
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
SN - 0939-6411
ER -
